Intelligence Β· Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs Β· EMA approved Β· by data quality Β· Page 8 of 39

  1. parathyroid hormone

    NATPAR Takeda

    INJECTION FDA: approved Β· EMA: approved

    H05AA03
  2. patisiran

    ONPATTRO Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    N07
  3. pegcetacoplan

    EMPAVELI Swedish Orphan Biovitrum Pty Ltd

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· TGA: approved

    L04AJ03
  4. pegvaliase

    PALYNZIQ BioMarin Pharmaceutical Australia Pty Ltd

    EMA: approved

    A16AB19
  5. perampanel

    FYCOMPA Eisai Co.,

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    N03AX22
  6. pioglitazone

    ACTOS Alphapharm Pty Ltd

    EMA: approved Β· TGA: approved

    A10BD05
  7. pirfenidone

    ARX-PIRFENIDONE Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AX05
  8. plerixafor

    PLERIXAFOR ARX Lacuna Pharma Pty Ltd

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· TGA: approved

    L03AX16
  9. pomalidomide

    POMALIDOMIDE SANDOZ Lacuna Pharma Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AX06
  10. ponesimod

    PONVORY Vanda Pharmaceuticals Netherlands B.V.

    ORAL FDA: approved Β· EMA: approved

    L04AE04
  11. posaconazole

    PHARMACOR POSACONAZOLE Lacuna Pharma Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    J02AC04
  12. potassium citrate

    NULL Teva Pharma GmbH

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    A12BA30
  13. pramipexole

    APO-PRAMIPEXOLE Alphapharm Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    N04BC05
  14. pregabalin

    APO-PREGABALIN Viatris Pharmaceuticals Co.,

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    N02BF02
  15. prucalopride

    RESOLOR Takeda

    EMA: approved

    A06AX05
  16. radamts13

    ADZYNMA Takeda

    EMA: approved

    B01AD13
  17. raloxifene

    EVISTA Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    G03XC01
  18. ranolazine

    RANEXA (PREVIOUSLY LATIXA) Amneal Pharma Europe Ltd

    ORAL FDA: approved Β· EMA: approved

    C01EB18
  19. rasagiline

    ALZIRAS Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    N04BD02
  20. repaglinide

    REPAGLINIDE SUN Teva Pharma GmbH

    ORAL FDA: approved Β· EMA: approved

    A10BX02
  21. reslizumab

    CINQAERO Teva Pharma GmbH

    INJECTION FDA: approved Β· EMA: approved

    R03DX08
  22. resmetirom

    REZDIFFRA Madrigal Pharmaceuticals EU Limited

    ORAL FDA: approved Β· EMA: approved

    A05
  23. respiratory syncytial virus mrna vaccine

    MRESVIA Teva Pharma GmbH

    EMA: approved

    J07BX05
  24. riluzole

    PHARMACOR RILUZOLE Sanofi-aventis Healthcare Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    N07XX02

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.